• LAST PRICE
    7.7950
  • TODAY'S CHANGE (%)
    Trending Down-0.1450 (-1.8262%)
  • Bid / Lots
    7.7900/ 4
  • Ask / Lots
    7.8000/ 157
  • Open / Previous Close
    7.9800 / 7.9400
  • Day Range
    Low 7.7200
    High 8.1900
  • 52 Week Range
    Low 4.0000
    High 9.8599
  • Volume
    311,079
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 7.94
TimeVolumeATNM
09:32 ET87578.18
09:34 ET54008.12
09:36 ET7358.155
09:38 ET1008.1328
09:39 ET56108.145
09:43 ET10008.1359
09:45 ET4228.17
09:48 ET2008.155
09:50 ET20008.09
09:52 ET4008.12
09:56 ET10868.11
09:57 ET8008.11
09:59 ET8538.118
10:03 ET5238.142
10:06 ET13358.142
10:08 ET11228.13
10:10 ET3008.105
10:12 ET22838.0413
10:14 ET9568.02
10:15 ET21158.03
10:17 ET19007.98
10:19 ET330307.915
10:21 ET14097.89
10:24 ET31397.86
10:26 ET40007.9
10:28 ET15637.9088
10:30 ET11567.94
10:32 ET18627.9559
10:33 ET9007.92
10:35 ET111307.97
10:37 ET43767.99
10:42 ET2557.98
10:48 ET55427.98
10:50 ET1007.98
10:53 ET9557.9636
10:55 ET8007.99
10:57 ET66567.99
11:00 ET21257.99
11:04 ET27957.96
11:08 ET1007.91
11:09 ET10007.915
11:11 ET10007.92
11:13 ET44367.92
11:18 ET2007.935
11:22 ET26247.935
11:24 ET1007.92
11:26 ET2267.935
11:27 ET118387.88
11:29 ET9007.88
11:31 ET4547.89
11:33 ET25277.89
11:36 ET9057.87
11:38 ET19007.88
11:45 ET48347.92
11:51 ET11237.93
11:54 ET7007.94
11:56 ET2007.94
11:58 ET63637.945
12:00 ET32887.97
12:02 ET1107.98
12:03 ET47907.99
12:05 ET7428
12:07 ET14407.98
12:09 ET160927.9
12:12 ET1007.905
12:16 ET40047.825
12:18 ET16057.801
12:20 ET3007.83
12:32 ET3007.83
12:36 ET46157.785
12:38 ET1007.77
12:41 ET46907.75
12:43 ET13687.75
12:52 ET15007.78
12:56 ET7007.8
12:59 ET2007.79
01:01 ET11427.79
01:15 ET5537.785
01:17 ET13717.78
01:24 ET53007.82
01:26 ET5007.82
01:28 ET21517.86
01:30 ET3047.85
01:32 ET2277.8588
01:37 ET2007.84
01:44 ET1007.83
01:46 ET33407.76
01:50 ET1507.7605
01:51 ET36117.74
01:53 ET61007.745
01:55 ET129187.83
01:57 ET30007.835
02:00 ET6007.85
02:04 ET1007.88
02:06 ET2007.88
02:15 ET6007.8511
02:20 ET1007.84
02:22 ET1007.83
02:24 ET2507.83
02:26 ET44087.78
02:27 ET1007.78
02:29 ET83817.82
02:38 ET3377.81
02:40 ET2007.82
02:45 ET47027.795
02:47 ET10007.7998
02:49 ET1007.795
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesATNM
Actinium Pharmaceuticals Inc
217.7M
-4.1x
---
United StatesOVID
Ovid Therapeutics Inc
215.7M
-4.2x
---
United StatesOMER
Omeros Corp
215.0M
-1.2x
---
United StatesDSGN
Design Therapeutics Inc
220.9M
-3.3x
---
United StatesMACK
Merrimack Pharmaceuticals Inc
214.3M
-179.1x
---
United StatesINMB
INmune Bio Inc
209.6M
-7.7x
---
As of 2024-03-28

Company Information

Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A is a therapeutic agent, have demonstrated potential to extend survival outcomes for people with relapsed and refractory acute myeloid leukemia. The Company focuses on advance Iomab-B for other blood cancers and next generation conditioning candidate Iomab-ACT to improve cell and gene therapy outcomes. The Company holds patent applications including several patents related to the manufacture of the isotope Ac-225 in a cyclotron. Actinium-225 is a potent alpha-particle emitter that has high linear energy transfer capable of killing targeted cancer cells via double-strand breaks in DNA.

Contact Information

Headquarters
100 Park Ave., 23Rd FloorNEW YORK, NY, United States 10017
Phone
646-677-3870
Fax
845-818-3588

Executives

Chairman of the Board, Chief Executive Officer
Sandesh Seth
Chief Financial Officer
Steve O'Loughlin
Chief Business Officer
Lynn Bodarky
Independent Director
Jeffrey Chell
Lead Independent Director
C. David Nicholson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$217.7M
Revenue (TTM)
$0.00
Shares Outstanding
27.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.01
EPS
$-1.92
Book Value
$2.59
P/E Ratio
-4.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.